|
Volumn 22, Issue 14, 2012, Pages 4816-4819
|
Attenuation of collagen-induced arthritis by orally available imidazoline-based NF-κB inhibitors
|
Author keywords
Cytokines; Imidazolines; Inflammation; NF B; Rheumatoid arthritis
|
Indexed keywords
COLLAGEN ANTIBODY;
DEXAMETHASONE;
I KAPPA B;
IMIDAZOLINE DERIVATIVE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
TCH 013;
TCH 013A;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DRUG EFFICACY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
MOUSE;
NONHUMAN;
RHEUMATOID ARTHRITIS;
SIGNAL TRANSDUCTION;
ADMINISTRATION, ORAL;
ANIMALS;
ARTHRITIS, EXPERIMENTAL;
IMIDAZOLINES;
MICE;
MICE, INBRED BALB C;
NF-KAPPA B;
TUMOR NECROSIS FACTOR-ALPHA;
MUS;
|
EID: 84863464679
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.05.056 Document Type: Article |
Times cited : (6)
|
References (21)
|